文献速递鼻科小儿耳鼻咽喉

儿童慢性鼻窦炎患者微生物组研究

The microbiome of pediatric patients with chronic rhinosinusitis.
PubMed 文献 · Int Forum Allergy Rhinol · 2020-06-22

本研究比较接受腺样体切除术的儿童慢性鼻窦炎(CRS)患者与健康对照的微生物群。采集鼻咽(腺样体床)和鼻腔(鼻窦)样本行16S rRNA基因测序。结果显示鼻咽与鼻腔微生物组成和多样性存在差异,但CRS与对照组间无显著差异。

要点

  • 鼻咽与鼻腔微生物组成和多样性存在差异。
  • CRS与对照组间微生物组成和多样性无显著差异。
  • 鼻咽样本中Fusobacterium、Prevotella、Porphyromonas和Campylobacter相对丰度高于鼻腔。

核心结论

  • 鼻咽和鼻腔在微生物群组成和多样性上存在差异,但CRS与对照组间无显著差异。
  • 鼻咽和鼻窦的生态变化可能参与健康对照和CRS患者腺样体肥大的病因。

研究设计与样本

  • 接受腺样体切除术的阻塞性睡眠呼吸暂停患者(n=50)和CRS患者(n=37)被纳入研究。
  • 术前收集SNOT-22或SN-5问卷。
  • 术中采集鼻咽(腺样体床)和鼻腔(鼻窦)样本,行16S rRNA基因测序获得各样本分类群丰度。
  • 统计分析包括PERMANOVA、α多样性测量和分类群丰度变化。

主要发现

  • Moraxella是最丰富的微生物。
  • 鼻咽拭子α多样性高于鼻腔。
  • 多样性不因CRS或阻塞性睡眠呼吸暂停病史而不同。
  • 多样性随年龄增加而增加,湿疹导致鼻咽与鼻腔间多样性差异更大。
  • 腺样体大小不影响多样性;鼻用激素、吸入激素和抗组胺药影响鼻咽和鼻腔多样性。

临床怎么用

  • 儿童CRS微生物群评估需考虑采样部位(鼻咽 vs 鼻腔)的生态差异。
  • 鼻用激素、吸入激素和抗组胺药使用与微生物多样性相关,解读结果时应考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to compare the microbiota of pediatric patients with chronic rhinosinusitis (CRS) who are undergoing adenoidectomy to treat their disease with that of healthy control patients. METHODS: Patients undergoing adenoidectomy-only for obstructive sleep apnea (n = 50) and CRS (n = 37) were recruited. Preoperative 22-item Sino-Nasal Outcome Test (SNOT-22) or Sinus and Nasal Quality of Life Survey (SN-5) were collected. Each patient had samples collected from their nasopharynx (adenoid bed) and nasal cavity (sinus) at the onset of surgery. 16S ribosomal ribonucleic acid (rRNA) gene sequencing was subsequently performed to obtain per sample taxonomic abundances. Statistical analyses included permutational multivariate analysis of variance (PERMANOVA), alpha (within sample) diversity measures, and changes in taxonomic abundance. RESULTS: Moraxella was the most abundant organism. Nasopharyngeal swabs demonstrated higher alpha diversity compared to the nasal cavity. The diversity was not different based on CRS vs obstructive history. There was an increase in diversity with increasing age, and eczema contributed to a greater difference in diversity between the nasopharynx and nasal cavity. Diversity was not affected by adenoid size; however, use of nasal steroids, inhaled steroids, and antihistamines influenced diversity in both the nasopharynx and nasal cavity. Nasopharyngeal samples were higher in relative abundance for Fusobacterium, Prevotella, Porphyromonas, and Campylobacter compared to the nasal cavity. CONCLUSION: The nasopharynx and nasal cavity differed in both microbiota composition and diversity. In contrast, no significant difference in composition or diversity were found in CRS vs control patients. Ecological changes in the nasopharyngeal and sinus site may contribute to the etiology for adenoid hypertrophy in both healthy controls and CRS patients.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Stapleton AL, Shaffer AD, Morris A, et al. The microbiome of pediatric patients with chronic rhinosinusitis. Int Forum Allergy Rhinol. 2020. PMID: 32348024. doi:10.1002/alr.22597

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。